Literature DB >> 14683421

The genetic polymorphism of drug transporters: functional analysis approaches.

Toshihisa Ishikawa1, Akira Tsuji, Kenichi Inui, Yoshimichi Sai, Naohiko Anzai, Morimasa Wada, Hitoshi Endou, Yasuhiro Sumino.   

Abstract

Evidence is accumulating to strongly suggest that drug transporters are one of the determining factors governing the pharmacokinetic profile of drugs. To date, a variety of drug transporters have been cloned and classified as solute carriers and ATP-binding cassette transporters. Such drug transporters are expressed in various tissues such as the intestine, brain, liver, and kidney, and play critical roles in the absorption, distribution and excretion of drugs. However, at the present time, information is limited regarding the genetic polymorphism of drug transporters and its impact on their function. In this context, we have undertaken the functional analyses of the polymorphisms identified in drug transporter genes. This article aims to provide an overview on the functional aspects of the non-synonymous polymorphisms of drug transporters and to present standard methods for the evaluation of the effect of polymorphisms on their function.

Mesh:

Substances:

Year:  2004        PMID: 14683421     DOI: 10.1517/phgs.5.1.67.25683

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  9 in total

Review 1.  Pharmacogenomics of the human ABC transporter ABCG2: from functional evaluation to drug molecular design.

Authors:  Toshihisa Ishikawa; Ai Tamura; Hikaru Saito; Kanako Wakabayashi; Hiroshi Nakagawa
Journal:  Naturwissenschaften       Date:  2005-10

2.  Meta-analysis of effects of ABCB1 polymorphisms on clopidogrel response among patients with coronary artery disease.

Authors:  Yajing Zhai; Hairong He; Xiancang Ma; Jiao Xie; Ti Meng; Yalin Dong; Jun Lu
Journal:  Eur J Clin Pharmacol       Date:  2017-04-05       Impact factor: 2.953

3.  Opioid-induced respiratory depression: ABCB1 transporter pharmacogenetics.

Authors:  S Sadhasivam; V Chidambaran; X Zhang; J Meller; H Esslinger; K Zhang; L J Martin; J McAuliffe
Journal:  Pharmacogenomics J       Date:  2014-10-14       Impact factor: 3.550

4.  Characteristics of successful recruitment in prospective pediatric pharmacogenetic studies.

Authors:  Shannon N Saldaña; David K Hooper; Tanya E Froehlich; Kathleen M Campbell; Cynthia A Prows; Senthilkumar Sadhasivam; Todd G Nick; Michael Seid; Alexander A Vinks; Tracy A Glauser
Journal:  Clin Ther       Date:  2011-12-02       Impact factor: 3.393

5.  Pharmacokinetic significance of renal OAT3 (SLC22A8) for anionic drug elimination in patients with mesangial proliferative glomerulonephritis.

Authors:  Yuji Sakurai; Hideyuki Motohashi; Ken Ogasawara; Tomohiro Terada; Satohiro Masuda; Toshiya Katsura; Noriko Mori; Motokazu Matsuura; Toshio Doi; Atsushi Fukatsu; Ken-ichi Inui
Journal:  Pharm Res       Date:  2005-11-01       Impact factor: 4.200

Review 6.  Pharmacogenomics of human ABC transporter ABCC11 (MRP8): potential risk of breast cancer and chemotherapy failure.

Authors:  Yu Toyoda; Toshihisa Ishikawa
Journal:  Anticancer Agents Med Chem       Date:  2010-10-01       Impact factor: 2.505

7.  Role of ABC transporters in cancer chemotherapy.

Authors:  Yue-Li Sun; Atish Patel; Priyank Kumar; Zhe-Sheng Chen
Journal:  Chin J Cancer       Date:  2012-01-17

Review 8.  How drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusion.

Authors:  Douglas B Kell; Stephen G Oliver
Journal:  Front Pharmacol       Date:  2014-10-31       Impact factor: 5.810

Review 9.  The Transporter-Mediated Cellular Uptake and Efflux of Pharmaceutical Drugs and Biotechnology Products: How and Why Phospholipid Bilayer Transport Is Negligible in Real Biomembranes.

Authors:  Douglas B Kell
Journal:  Molecules       Date:  2021-09-16       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.